Literature DB >> 1180575

Selection of patients and operative approach in primary aldosteronism.

T K Hunt, M Schambelan, E G Biglieri.   

Abstract

A system for discriminating between adrenal adenoma and hyperplasia based on the levels of aldosterone production, plasma renin concentration, severity of electrolyte disturbances, plasma aldosterone patterns during recumbency and after assuming erect posture, and 131I-19-iodocholesterol scan has been developed. Indicated for operation are patients with adenomas whose elevated blood pressure cannot be continuously controlled with usual doses of medication and patients with documented deterioration of target organ function. Adrenalectomy has been performed 83 times in 81 patients with a diagnosis of primary hyperaldosteronism. Results of excision of adrenal adenomas have been excellent with significant lowering of blood pressure in all cases and cure of hypertension in over 60%. Results of total or subtotal adrenalectomy for hyperplasia have been poor with almost all patients still requiring medication for hypertension. Adenomas have always been unilateral, and usually can be localized so that unilateral exploration is curative. Therefore, we have tried to distinguish preoperatively between adenoma and hyperplasia. Anterior transperitoneal adrenalectomy has been effective with few complications, and no postoperative hypercortisolism after unilateral adrenalectomy for adenoma. The unilateral extraperitoneal approach gives shorter morbidity and potentially fewer serious complications.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1180575      PMCID: PMC1343991          DOI: 10.1097/00000658-197510000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

Review 1.  Adrenal mineralocorticoids causing hypertension.

Authors:  E G Biglieri; J R Stockigt; M Schambelan
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

2.  Role of renin and aldosterone in hypertension due to a renin-secreting tumor.

Authors:  M Schambelan; E L Howes; C A Noakes; E G Biglieri
Journal:  Am J Med       Date:  1973-07       Impact factor: 4.965

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1972.

Authors:  B Castleman; R E Scully; B U McNeely
Journal:  N Engl J Med       Date:  1972-09-28       Impact factor: 91.245

4.  The intercurrent hypertension of primary aldosteronism.

Authors:  E G Biglieri; M Schambelan; P E Slaton; J R Stockigt
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

5.  Diagnosis of adrenal disease by visualization of human adrenal glands with 131 I-19-iodocholesterol.

Authors:  L M Lieberman; W H Beierwaltes; J W Conn; A N Ansari; H Nishiyama
Journal:  N Engl J Med       Date:  1971-12-16       Impact factor: 91.245

6.  Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.

Authors:  J Aitchison; J J Brown; J B Ferriss; R Fraser; A W Kay; A F Lever; A M Neville; T Symington; J I Robertson
Journal:  Am Heart J       Date:  1971-11       Impact factor: 4.749

7.  Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.

Authors:  W W Davis; H H Newsome; L D Wright; W G Hammond; J Easton; F C Bartter
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

8.  Management of primary aldosteronism: evaluation of potassium and sodium balance, technic of adrenalectomy and operative results in 24 cases.

Authors:  W Silen; E G Biglieri; P Slaton; M Galante
Journal:  Ann Surg       Date:  1966-10       Impact factor: 12.969

  8 in total
  8 in total

1.  The incidentally discovered adrenal mass.

Authors:  P M Copeland
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

2.  Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  H Witzgall; O A Müller; P C Weber
Journal:  Klin Wochenschr       Date:  1983-01-03

3.  The management of patients with primary aldosteronism.

Authors:  P O Granberg; U Adamson; K H Cohn; B Hamberger; P E Lins
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

4.  Primary aldosteronism caused by an adrenal tumor: a correctable cause of hypertension.

Authors:  R J Smith; W L Faulkner
Journal:  J Natl Med Assoc       Date:  1993-10       Impact factor: 1.798

5.  Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions.

Authors:  T Nakada; H Koike; T Akiya; T Katayama; M Takata; H Iida; Y Mizumura
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

6.  Evolution of the surgical management of primary aldosteronism.

Authors:  S P Auda; M F Brennan; J R Gill
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

7.  Urinary kallikrein excretion in essential and mineralocorticoid hypertension.

Authors:  O B Holland; J M Chud; H Braunstein
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

8.  Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma.

Authors:  Y Ito; Y Fujimoto; T Obara; T Kodama
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.